Wilmington, DE, United States of America

Megan Murphy King




Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Megan Murphy King: Innovator in Pharmaceutical Chemistry

Introduction

Megan Murphy King is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. Her work focuses on innovative compounds that have the potential to impact medical treatments.

Latest Patents

Megan's latest patents include N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide and its pharmaceutically acceptable salts, as well as methods of treatment and processes for making these compounds. These inventions highlight her expertise in developing complex pharmaceutical compositions and their applications in healthcare.

Career Highlights

Megan is currently employed at AstraZeneca AB, where she continues to advance her research and development efforts. Her work at AstraZeneca has positioned her as a key player in the pharmaceutical industry, contributing to the development of innovative treatments.

Collaborations

Megan collaborates with talented professionals such as Cathy Dantzman and Glen E Ernst. These partnerships enhance her research capabilities and foster a collaborative environment for innovation.

Conclusion

Megan Murphy King is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new medical treatments. Her contributions and collaborations reflect her commitment to advancing healthcare through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…